Alessandro Riva
Tracked across 1 events · 6 articles · First seen Apr 13, 2026 · Last active May 31, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Alessandro Riva, Chairman and CEO of Transgene, commented on the importance of completing patient randomization in the Phase 2 study for TG4050.
Apr 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Alessandro Riva live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard